Gregory D. Casciaro

is currently Chief Executive Officer and President at Cardiac Dimensions, Inc., a medical device company developing products to treat heart failure. He has been a Director of Apama Medical a medical device company in the Atrial Fibrillation sector since December 2014. Greg serves as a director with Dextera Surgical Inc, (DXTR) since December 2014 and serves as a director of QT Vascular Ltd., a medical device company, since 2001. Prior to QT Vascular, Mr. Casciaro served as the President and Chief Executive Officer of AccessClosure, Inc., a medical device company that was acquired by Cardinal Health, Inc. Prior to joining AccessClosure, he was the president, CEO and a director of XTENT, Inc., a medical device company that was acquired by Biosensors International Group, Ltd. Previously, Mr. Casciaro served as the President, Chief Executive Officer and a director of Orquest Inc., a private company manufacturing and selling bio-therapeutic products to the orthopedic market. Mr. Casciaro previously served as a director of AngioDynamics, Inc. and Kerberos Proximal Solutions. He was president, Chief Executive Officer and a director at General Surgical Innovations, Inc., a laparoscopic surgical equipment manufacturer that was acquired by United States Surgical, a division of Tyco Healthcare Group, and held executive and management positions at Vascular Intervention, a division of Guidant Corporation, North American Instrument Corporation, and Procter & Gamble Co. Mr. Casciaro graduated from Marquette University with a B.A. in Business Administration.